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This study describes the characterisation of whey protein hydrolysates obtained from tryptic hydrolysis to assess their application as
ingredients with angiotensin-converting-enzyme (ACE) inhibitory action. The levels of a-lactalbumin (a-la) and b-lactoglobulin (b-lg)
remaining after hydrolysis were quantiﬁed. Peptides were separated by RP-HPLC, and Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR), the
most potent b-lg-derived ACE-inhibitory peptide was monitored. A correlation curve was established for the production of this peptide
as a function of hydrolysis time. Heat-induced gelation of hydrolysates was studied by small-deformation rheology. The gelation times
and the strength of the ﬁnal gels were highly dependent on the degree of hydrolysis. Smaller peptides liberated by hydrolysis contributed
to the inability of whey protein hydrolysates to gel.
r 2006 Elsevier Ltd. All rights reserved.
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Whey ingredients are used throughout the world in
beverages, bars and other food systems. Newer whey
ingredients include hydrolysed whey proteins that contain
high levels of bioactive peptides (Foegeding, Davis,
Doucet, & McGuffey, 2002; Gauthier & Pouliot, 2003;
Meisel, 1998). These hydrolysates can be added to special
foods to increase value, as enzymatic hydrolysis can
optimise their functional properties (e.g., gelling, emulsify-
ing and foaming capacities and solubility) (De Wit, 1998;
Melachouris, 1984; Zydney, 1998). Thus, there is consider-
able commercial interest in the preparation of wheye front matter r 2006 Elsevier Ltd. All rights reserved.
airyj.2006.06.023
ing author. Tel.: +351 22 2078929; fax: +351 22 2003977.
ess: isabel.ferreira@ff.up.pt (I.M.P.L.V.O. Ferreira).proteins for food, nutraceutical, and therapeutic applica-
tions (Torres, 2005).
Bioactive peptides are often inactive within the sequence
of the parent protein and can be released, for example, by
enzymatic hydrolysis with digestive enzymes. Bioactive
peptide fragments originating from whey proteins should
be taken into account as components that have a positive
effect on cardiovascular health (Clare & Swaisgood, 2000;
Pihlanto-Leppala, Koskinen, Piilola, Tupasela, & Korho-
nen, 2000; Seppo, Jauhiainen, Poussa, & Korpela, 2003;
Yusuf, Lonn, Bosch, & Gerstein, 1999). For example,
certain bioactive peptides may protect against hypertension
through angiotensin-converting-enzyme (ACE)-inhibition
and opioid-like activity, both in vitro and in animal
experiments. The overall effect of an ACE inhibitor is the
control of high blood pressure through dilation of blood
vessels and its effect on blood volume (Belem, Gibbs, &
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& Takano, 1996; Mullally, Meisel, & FitzGerald, 1997a;
Pihlanto-Leppala, Rokka, & Korhonen, 1998; Sipola et al.,
2000; Walsh et al., 2004).
In recent research, ACE-inhibition fragments from both
a-lactalbumin (a-la) and b-lactoglobulin (b-lg) were identi-
ﬁed. It has been shown that ACE prefers substrates
containing a hydrophobic (aromatic or branched side-
chains) amino acid residue at the C-terminal position.
Whey fractions hydrolysed with trypsin showed ACE-
inhibition activity (Mullally, Meisel, & FitzGerald, 1997b).
ACE inhibition is measured by the concentration of
substance needed to inhibit 50% of the original ACE
activity (IC50). A lower IC50 value indicates higher efﬁcacy.
Published research studies on ACE inhibitory activity of
various whey-derived peptides show results at a level of
77–1062 mM (Mullally et al., 1997a; Pihlanto-Leppala
et al., 2000).
When developed as food ingredients, the processing of
these antihypertensive peptides is vital to their activity. For
example, heat treatments will have negative effects on the
bioavailability of whey peptides, so processors must
carefully monitor production parameters. Appropriate
selection of enzymes for proteolysis will result in maximum
biological activity and will limit the development of bitter
ﬂavour notes, with low cost. Trypsin is an interesting
enzyme for the liberation of bioactive peptides, and also for
the improvement of protein digestibility and for decreasing
protein allergenicity, due to its speciﬁcity (Mullally et al.,
1997b).
Additionally, it is important to study the functional
properties of hydrolysates, because hydrolysis produced
with different proteolytic enzymes can increase solubility
and change gelling properties. Some enzymes can induce
gelation following whey protein hydrolysis; others impair
gelling properties (Doucet, Gauthier, & Foegeding, 2001;
Foegeding et al., 2002; Otte, Lomholt, Ipsen, & Qvist,
2000). Gels confer structure, texture and stability to food
products; they also allow the retention of large quantities
of water and other small molecules inside the food matrix.
These aspects are appreciated by processed food manu-
facturers.
Whey protein concentrates with 80% protein are
frequently used to fortify various food products, owing
to their low fat and lactose contents and high protein levels.
This study describes the characterisation of hydrolysates of
these whey protein concentrates produced using trypsin
with different degrees of hydrolysis. For that purpose,
whey protein concentrates were hydrolysed with trypsin to
ﬁve different degrees of hydrolysis and the remaining levels
of a-la and b-lg were quantiﬁed. The resulting peptides
were separated by reversed phase high-performance liquid
chromatography (RP-HPLC), and the most potent b-lg-
derived ACE inhibitory peptide, Ala-Leu-Pro-Met-His-Ile-
Arg (ALPMHIR) reported to date (Mullally et al., 1997b),
was identiﬁed and selected to characterize ACE-inhibitory
activity of hydrolysates. Additionally, heat-induced gela-tion of three hydrolysates was studied by small-deforma-
tion rheology.
2. Experimental
2.1. Substrate and enzymes
A commercial spray-dried whey protein concentrate
(WPC) from bovine milk with 80%, w/w, protein (WPC
80), Oragel HG80 from Armor Proteins (Saint Brice en
Cogles, France) was used as substrate.
Trypsin from porcine pancreas with an activity of 1800
BAEE unitsmg1 of protein (1U hydrolyses 1 mmol of
N-a-benzoy-L-arginine ethyl ester (BAEE) in a reaction
volume of 3.2mL and 1 cm light path at pH 7.6 at 25 1C)
was obtained from Sigma Chemical Co (St. Louis, MO,
USA).
2.2. Hydrolysis of WPC 80
Solutions of WPC (prepared by suspending 2.5 g WPC in
50mL of distilled water) were warmed to the hydrolysis
temperature (37 1C) and adjusted to pH 8.0 with 1M
NaOH. Enzymatic degradations were performed in a
0.05 L stirred, tank-type, batch reactor equipped with pH
and temperature control. The pH was maintained at 8.0
with 0.25mol L1 NaOH and the temperature was
constant at 37 1C. Trypsin was added at a concentration
of 0.2 gL1, and the degree of hydrolysis (DH %) achieved
was measured by the pH-stat method (Adler-Nissen, 1986).
Five experiments were performed using the same initial
conditions; the hydrolysis reaction was stopped at ﬁve
different times (15, 30, 60, 120 and 180min) by heating at
80 1C for 5min. Five resulting whey protein hydrolysates
(WPH) were lyophilised using a CHRIST Alpha 2–4
system (B. Braun Biotech International, Osterode/Harz,
Germany).
2.3. Physicochemical analysis
The moisture and ash contents were determined accord-
ing to Food Chemical Codex (FCC, 1981a, b). Total
protein content was determined according to the AOAC
method (2000). Lactose analyses were carried out in an
analytical HPLC unit (Jasco, Tokyo, Japan), equipped
with a low-pressure quaternary pump (PU-1580), an
evaporative light-scattering detector (LSD-Sedex 75, Al-
fortville, France) and a type 7125 Rheodyne Injector with a
10 mL loop. A Borwin Controller Software (JMBS Devel-
opments, Le Fontanil, France) was also used. The column
was a Spherisorb NH2, 5 mm, 250mm length 4.6mm
internal diameter (Waters Corporation, Massachusetts,
Ireland). Elution was carried out with a mixture of 81%
acetonitrile and 19% of water for 20min. The ﬂow-rate
was 1mLmin1. The temperature of the heated drift tube
was 45 1C, the gas pressure was 3.0 bar, and gain 5. Sample
preparation involved homogenisation of 200mg of WPC80
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(40:60), followed by ﬁltration with 0.45 mm Teknokroma
(TR-200106-PVDF, 25mm Ø, PK/100) syringe ﬁlters
(Teknokroma, Madrid, Spain).(b)
(a)
ce
 u
ni
ts2.4. Chromatographic analysis of peptides and proteins
RP-HPLC was used for the separation of b-lg, a-la and
the resulting peptides produced by hydrolysis. An analy-
tical HPLC unit (Jasco) with a Chrompack P-300-RP
column was used. Gradient elution was carried out with a
mixture of two solvents (solvent A: 0.1% triﬂuoroacetic
acid (TFA) in water and solvent B: 0.1% TFA in 80%
aqueous acetonitrile, [v/v]). Proteins and peptides were
eluted as follows: 0–1min, 90% A; 1–10min, 90–80% A;
10–15min, 80–75% A; 15–20min, 75–60% A; 20–30min,
60–50% A; 30–33min, 50–40% A; 33–36min, 40–30% A;
36–39min, 30–20% A; 39–41min, 20–0% A. The ﬂow-rate
was 0.5mLmin1. The column was held at ambient
temperature and detection was at 215 nm. Total run time
was 50min.
Prior to analysis by RP-HPLC, WPC and WPH were
diluted with ultra-puriﬁed water, 0.5 gmL1 and 100 mL
were injected. Standards of bovine b-lg and a-la were
supplied by Sigma Chemical Co and dissolved in ultra-
puriﬁed water that possessed a resistance greater than
15MO. Under the conditions used, the major whey
proteins, a-la and b-lg, were well separated and exhibited
retention times of 34.5 and 37.5min, respectively. The
chromatographic system was calibrated by the external
standard method with solutions that contained bovine a-la
in the range 0.039–1.0mgmL1 and bovine b-lg in the
range 0.0039–1.0mgmL1, the purity of the standards was
taken in consideration.
Peptides that eluted around 30% acetonitrile were
collected and lyophilised for further sequencing by auto-
mated Edman degradation. Peptide sequence was deter-
mined by automated Edman degradation using an Applied
Biosystem LC 491 Protein Sequencer (Foster City, USA),
after chromatographic separation, collection and freeze-
drying. The lyophilised ALPMHIR peptide was used as
standard for quantiﬁcation of this peptide in hydrolysates,
using an external standard method.WPC80
WPH 0.9
WPH 2.2
WPH 4.2
(c)
*
*
*
Time (min)
20 40
A
bs
or
ba
n
Fig. 1. Typical chromatogram of WPC and three tryptic hydrolysates
(WPH0.9, WPH2.2, WPH4.2). (a) b-lg, (b) a-la, (c) the dotted box in the
ﬁgure points out the elution of tryptic peptides. *Peptide identiﬁed as
ALPMHIR. Wavelength of absorbance was 215 nm. In the chromato-
grams for WPH 0.9; WPH 2.0 and WPH 4.2 the zero-time was successively
shifted towards the right to show the changes in peaks throughout
hydrolysis.2.5. Rheological measurements
The lyophilised WPH was ﬁrst dispersed in 19mM
phosphate buffer (pH 7.0) to obtain a ﬁnal concentration
of 12%. Protein/hydrolysate concentration for the rheolo-
gical experiments was limited by the solubility of the less
hydrolysed WPH and gelation (even slight) of the most
hydrolysed WPH. Hydration of proteins/peptides occurred
at room temperature, over 3 h, under gentle stirring.
Finally, the ionic strength of the medium was adjusted to
220mM (expressed as NaCl concentration) by addition
of NaCl.Rheological measurements were performed with a
controlled-stress rheometer AR2000 (TA Instruments,
Delaware, USA) ﬁtted with a rough acrylic plate geometry
(40mm diameter, gap 500 mm). The samples were covered
with a thin layer of liquid parafﬁn to prevent evaporation,
after having been placed in the measuring device. Each
sample was submitted to a temperature ramp from 20 to
80 1C, at a rate of 2 1Cmin1; then, the temperature was
maintained at 80 1C for 3.5 h. At the end of this time sweep,
a frequency sweep (‘‘mechanical spectrum’’) was recorded
over the range 0.06–62.83 rad s1. The sample was then
cooled back to 20 1C, at the same constant rate
(2 1Cmin1 yr, and held at 20 1C for 1 h. Finally, another
frequency sweep (0.06–62.83 rad s1) was recorded at this
temperature. During the temperature, time and frequency
sweep measurements, a maximum shear strain of 1% was
used. Temperature and time sweeps were performed at
6.28 rad s1.3. Results
3.1. Characterization of WPC 80 Trypsin hydrolysates
The composition of WPC 80 and its WPH at ﬁve different
degrees of hydrolysis (0.9, 2.2, 2.5, 2.8 and 4.2%) showed no
signiﬁcant differences between moisture, ash, protein,
lactose and fat contents of the ﬁve WPH (po0.01) using
ANOVA. Mean values were 8.0670.4%, 4.6670.45%,
70.371.2%, 7.7170.22% and 9.4870.45%, respectively.
The disappearances of a-la, b-lg and the appearance of
peptides were evaluated by HPLC (Fig. 1). Hydrolysis of a-
la was almost complete after 15min. In contrast, hydrolysis
of b-lg was slower, and about 42% of the initial level of this
protein was intact after 180min of incubation. Concentra-
tions of b-lg quantiﬁed by HPLC are presented in Table 1.
In an earlier work performed using different experimental
conditions, correlation curves for the hydrolysis of b-lg
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According to that study, the change in level of b-lg during
hydrolysis was hyperbolic; the following equation was used
for the model:
bLG ¼ a  t=ðb þ tÞ, (1)
where a and b are constants, bLG is b-lg hydrolysis (% wt)
and t is hydrolysis time (in minutes).
In order to obtain these constants, the inverse of bLG
values were plotted against the inverse of time values so
that a linear representation could be obtained and
constants calculated:
1=bLG ¼ ðb=a  1=tÞ þ 1=a. (2)
The linear functions obtained presented acceptable
correlation coefﬁcients. The correlation curve for hydro-
lysis of b-lg under the same conditions used in this work
was:
bLG ¼ 91:7t=ð102þ tÞ. (3)
A comparison between experimental and calculated
(using Eq. (3)) concentrations of b-lg in WPC80 and its
hydrolysates is presented in Table 1. The correlation
between experimental and calculated data for hydrolysis
of b-lg was 0.9995.
Hydrolysis with trypsin led to the production of a large
number of peptides (Fig. 1). The average retention times
for the seven major peaks, in order of increasing elution
times, were 18.8, 22.4, 23.6, 25.9, 26.5, 29.4, and 31.7min,
respectively.
Mullally et al. (1997b) described that hydrolysis of b-lg
with trypsin released ACE-inhibitory activity peptides
eluting at around 30% acetonitrile, and the most potent
peptide was f(142–148), with a charge-to-mass ratio of
837.05. This peptide had an IC50 value of 42.6 mmolL
1.
Much speculation has been presented as to the contribu-
tion of speciﬁc amino acid residues/sequences to ACE-
inhibitory potency. Peptides containing hydrophobic ami-
no acids at the three C-terminal positions are reported to
be potent ACE-inhibitors (Cheung, Wang, Ondetti, Sabo,
& Cushma, 1980; Saito, Wanezaki, Kawato, & Imayasu,
1994). Furthermore, structure-activity data suggest that a
positive charge, as on the guanidine group of the
C-terminal Arg, contributes substantially to the ACE-
inhibitory potency of several peptides (Meisel, 1993). The
sequence of the f(142–148) peptide, Ala-Leu-Pro-Met-His-
Ile-Arg (ALPMHIR), reﬂects these observations. It is
interesting to point out that the resistance of this tryptic
peptide to further degradation by pepsin and chymotrypsin
is controversial (Mullally et al., 1997b; Walsh et al., 2004).
Mullally et al. (1997b) demonstrated that this peptide was
essentially resistant to further degradation by pepsin and
chymotrypsin but Walsh et al. (2004) demonstrated that
synthetic ALPMHIR was rapidly degraded upon incuba-
tion with human serum.
The peptide f(142–148) does not have the potency of
Captopril (a commercial drug inhibitor of ACE, with
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Fig. 2. Plot showing the production of peptide ALPMHIR as a function
of time. The linear function that enabled determination of equation curve
was: %ALPMHIR ¼ ð1:585t=85:09þ tÞ ___ theoretical data; ’ experi-
mental data.
Fig. 3. Changes in the elastic (G0) and viscous (G00) moduli of whey protein
hydrolysate dispersions during thermal gelation.
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able with those found for other food-derived peptides with
potential signiﬁcant physiological effects as antihyperten-
sive agents (Mullally et al., 1997b).
Edman sequencing revealed that the peptide with a
retention time of 23.6min from the chromatogram was
ALPMHIR. Its concentrations in the ﬁve tryptic hydro-
lysates (WPH) are presented in Table 1. The extent of
release of ALMPHIR, i.e., the actual amount detected and
the theoretically expected amount from a known quantity
of b-lg in the WPC starting substrate, were in good
agreement.
A correlation curve was established for the production of
the peptide ALPMHIR against hydrolysis time (Fig. 2).
The linear function that enabled determination of equation
curve were Eq. (4). and (5). The correlation between
experimental and calculated data was 0.9968.
1
%ALPMHIR
¼ 53:70 1
t
þ 0:631, (4)
%ALPMHIR ¼ 1:585t
85:09þ t . (5)
High hydrolysis times, 4120min, were required to
guarantee that more than 50% of b-lg is hydrolysed and
a signiﬁcant amount of this peptide that is a potent
inhibitor of ACE in vitro is formed. Concerning the
antihypertensive potential of this peptide, it should be
pointed out that it is dependent on its ability to be
absorbed through the small intestine and to reach target
organs without being degraded or inactivated by gastro-
intestinal or plasma proteinases and peptidases. Few
studies in humans have been performed (Walsh et al.,
2004).3.2. Rheology
Whey proteins in aqueous dispersions, like other
globular proteins, can form gels during heating if the
protein concentration (C) is greater than the critical
concentration for gelation (C0) and the temperature (T) is
greater than the denaturation temperature of the proteins
(Td) (Clark, 1992). Fig. 3 presents the behaviour of the
elastic and the viscous moduli of three WPH dispersions
during the thermal process applied. The initial dispersions
had the same total protein concentration (17%, w/w), the
ionic strength was 200mM, expressed in NaCl concentra-
tion, and the pH was 7.0; they differed only in the degree of
hydrolysis of each hydrolysate involved.
During thermal gelation the elastic modulus (G0) starts to
increase and eventually crosses the viscous modulus (G00).
Gelation time (tg) for protein dispersions is the moment
when G0 ¼ G00 (Ikeda, Nishinari, & Foegeding, 2001), at tg,
only some protein aggregates are incorporated on the
incipient initial three-dimensional network. From that
moment, the sol fraction decreases with the incorporation
of protein molecules or aggregates in the network (core of
ARTICLE IN PRESS
Table 2
Rheological parameters of whey protein gels
WPH tg (h) Final gel (after 5.5 h)
G0 (kPa) G00 (kPa)
0.9 0.4a 12.0 2.6
2.2 0.7b 2.8 0.4
4.2 2.9b 0.05 0.02
atg occurs during heating step (20–80 1C).
btg occurs during kinetics (80 1C).
I.M.P.L.V.O. Ferreira et al. / International Dairy Journal 17 (2007) 481–487486the gel). The rheological parameters G0 and G00 start to
increase at different rates, i.e. 4dG0/dtbdG00/dt, which
reﬂects the increase in the elasticity of the gel; then, limit
values are reached with G0bG00 (Clark, 1992; Gosal and
Ross-Murphy, 2000).
After that, during the cooling process, G0 and G0 increase
signiﬁcantly due to the increase in non-covalent intra- and
inter-molecular interactions, resulting in the loss of
mobility of the proteins (Renkema, 2001). Spectroscopic
studies reveal that hydrogen bonds mainly contribute to
the hardening of the whey protein gels (Lefe`bvre and
Subirade, 2000).
The gelation time (when G0 equal G00) was highly
dependent on the degree of hydrolysis, as well as the
strength of the ﬁnal gels (compare ﬁnal values of G0 for
each gel), as depicted in Table 2. This behaviour can be
explained mainly by the reduced amount of available intact
protein for building structure. The stabilisation of the
bigger peptides and proteins (components with tertiary
structure) by smaller peptides liberated by hydrolysis has
also to be considered. Huang, Catignani, and Swaisgood
(1999) have reported this effect with the tryptic hydrolysis
of a whey protein isolate and have attributed the loss of
gelling ability to the stabilisation of b-lg (the main whey
protein involved in the gelling phenomena) by a hydro-
phobic peptide liberated during tryptic hydrolysis.
4. Conclusions
ALPMHIR, the most potent b-lg derived ACE-inhibi-
tory peptide, was assayed and a correlation curve was
established for the formation of this peptide during
hydrolysis with trypsin. Extensive hydrolysis was required
to obtain peptides suitable for functional ingredients,
namely ACE-inhibitory effect, more effective gastrointest-
inal absorption and reduced food allergies. However,
smaller peptides liberated by hydrolysis lead to the inability
of WPHs to form gel. Thus, the modulation of the gelling
properties of whey proteins by enzymatic hydrolysis allows
the incorporation of these ingredients, with ACE-inhibi-
tory peptides, in liquid and semi-solid foods with high
protein content (e.g., functional drinks with high protein
content, dairy desserts, culinary sauces, etc.).
More studies are needed to establish the antihypertensive
potential of this peptide in human beings, since this effect isdependent on the ability of this peptide to be absorbed
through the small intestine and to reach target organs
without being degraded or inactivated by gastrointestinal
or plasma proteinases and peptidases.
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